Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamphetamine enhances explicit new word learning for novel objects.

Emma Whiting1, Helen Chenery, Jonathan Chalk

  • 1Division of Speech Pathology, The University of Queensland, St Lucia, Queensland, Australia.

The International Journal of Neuropsychopharmacology
|January 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimising communication function in primary brain tumour: a randomised controlled trial of CanCommunicate.

Disability and rehabilitation·2026
Same author

Introduction of a National Foundation Year 1 Mentoring Programme.

Cureus·2025
Same author

Refining Methods of Experience-Based Co-Design for Application in Aphasia and Cognitive-Communication Disability.

American journal of speech-language pathology·2025
Same author

Successful Meek skin grafting combined with a synthetic dermal matrix in a patient with epidermolysis bullosa.

Journal of wound care·2025
Same author

Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trial.

BMJ neurology open·2025
Same author

Feasibility of delivering TeleCHAT: A comprehensive high-dose aphasia treatment via telerehabilitation.

Clinical rehabilitation·2025
Same journal

Genetic overlap between treatment-resistant schizophrenia and smoking initiation.

The international journal of neuropsychopharmacology·2026
Same journal

External Validation as the Critical Step for Predictive Biomarkers.

The international journal of neuropsychopharmacology·2026
Same journal

Viloxazine occupies the 5-HT2C receptor in the macaca fascicularis brain in vivo: A [11C]CIMBI-36 positron emission tomography study.

The international journal of neuropsychopharmacology·2026
Same journal

Divergent effects of interleukin-6 and ghrelin on remission and relapse in depression treatment.

The international journal of neuropsychopharmacology·2026
Same journal

Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program.

The international journal of neuropsychopharmacology·2026
Same journal

Recent cannabis exposure and acute nicotine effects: insights from randomized, double-blind, placebo-controlled intravenous nicotine studies.

The international journal of neuropsychopharmacology·2026
See all related articles

Dexamphetamine (Dex) improved the learning and retention of new object names in healthy young adults. This cognitive enhancement was linked to baseline attention and memory, suggesting effects on memory consolidation.

Area of Science:

  • Cognitive Neuroscience
  • Psychopharmacology

Background:

  • Previous studies indicate dexamphetamine (Dex) can enhance learning and memory in healthy individuals and those with neurological damage.
  • Explicit learning paradigms are crucial for understanding how cognitive enhancers affect memory formation.

Purpose of the Study:

  • To investigate the effects of Dex on the explicit learning of novel object names in young healthy adults.
  • To determine if Dex administration influences both the acquisition and long-term retention of new verbal information.

Main Methods:

  • A double-blind, placebo-controlled, between-subjects design was employed with 37 healthy young adults.
  • Participants received either 10 mg of Dex or a placebo daily for five days.
  • Learning involved viewing novel objects paired with non-word names, followed by retention tests at 1 week and 1 month.

Related Experiment Videos

Main Results:

  • Dex administration significantly enhanced the rate of learning new object names compared to the placebo group.
  • Improved retention of learned names was observed at both 1-week and 1-month follow-up assessments in the Dex group.
  • Word learning success in the Dex group correlated with baseline attention and memory scores, but not with sustained attention, mood, or cardiovascular arousal.

Conclusions:

  • Dexamphetamine effectively improves explicit word learning and memory retention in young healthy adults.
  • The observed cognitive benefits may be attributed to Dex-induced alterations in short-term memory or memory consolidation processes.
  • Individual differences in baseline cognitive functions may influence the efficacy of Dex as a cognitive enhancer.